Download Free Sample Report

This report contains market size and forecasts of Fidaxomicin in global, including the following market information:

• Global Fidaxomicin Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Fidaxomicin Market Sales, 2017-2022, 2023-2028, (K Tablets)
• Global top five Fidaxomicin companies in 2021 (%)

The global Fidaxomicin market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Purity:90% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Fidaxomicin include Astellas, Merck, Optimer Pharmaceuticals, Rochem, Tecoland, BrightGene Bio-Medical Technology, Olon and Livzon Group, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Fidaxomicin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Fidaxomicin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Tablets)
Global Fidaxomicin Market Segment Percentages, by Type, 2021 (%)

• Purity:90%
• Purity:95%
• Others

Global Fidaxomicin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Tablets)
Global Fidaxomicin Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Retail Pharmacies

Global Fidaxomicin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Tablets)
Global Fidaxomicin Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:

• Key companies Fidaxomicin revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Fidaxomicin revenues share in global market, 2021 (%)
• Key companies Fidaxomicin sales in global market, 2017-2022 (Estimated), (K Tablets)
• Key companies Fidaxomicin sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Astellas
• Merck
• Optimer Pharmaceuticals
• Rochem
• Tecoland
• BrightGene Bio-Medical Technology
• Olon
• Livzon Group